JMPR-related information

ADI/PTDI: 0-0.1 mg/kg bw (2016)
Residue definition:For compliance with the MRL and for dietary risk assessment for plant commodities: Sum of free and conjugated M4 (SYN 505164; 8-(2,6-Diethyl-4-hydroxymethyl-phenyl)-9-hydroxy-1,2,4,5-tetrahydro-pyrazolo[1,2-d][1,4,5]oxadiazepin-7-one), expressed as pinoxaden. For compliance with the MRL and for dietary risk assessment) for animal commodities: M4 (SYN 505164; 8-(2,6-Diethyl-4-hydroxymethyl-phenyl)-9-hydroxy-1,2,4,5-tetrahydro-pyrazolo[1,2-d][1,4,5]oxadiazepin-7-one), expressed as pinoxaden. The residue is not fat soluble.